160 related articles for article (PubMed ID: 7760450)
1. Cardiac arrest following an iatrogenic 3,4-diaminopyridine intoxication in a patient with Lambert-Eaton myasthenic syndrome.
Boerma CE; Rommes JH; van Leeuwen RB; Bakker J
J Toxicol Clin Toxicol; 1995; 33(3):249-51. PubMed ID: 7760450
[TBL] [Abstract][Full Text] [Related]
2. 3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Sanders DB; Howard JF; Massey JM
Ann N Y Acad Sci; 1993 Jun; 681():588-90. PubMed ID: 8357206
[No Abstract] [Full Text] [Related]
3. The myasthenic syndrome: anaesthesia in a patient treated with 3.4 diaminopyridine.
Telford RJ; Hollway TE
Br J Anaesth; 1990 Mar; 64(3):363-6. PubMed ID: 1970263
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Diaminopyridine, an orphan drug, in the symptomatic treatment of Lambert-Eaton myasthenic syndrome.
Molgó J; Guglielmi JM
Pflugers Arch; 1996; 431(6 Suppl 2):R295-6. PubMed ID: 8739381
[TBL] [Abstract][Full Text] [Related]
5. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS).
Sanders DB
Ann N Y Acad Sci; 1998 May; 841():811-6. PubMed ID: 9668334
[No Abstract] [Full Text] [Related]
7. Treatment for Lambert-Eaton myasthenic syndrome.
Keogh M; Sedehizadeh S; Maddison P
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD003279. PubMed ID: 21328260
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Lambert-Eaton syndrome with 3,4- diaminopyridine and pyridostigmine].
Yachachi Monfort A; Cortés Pastor F; de la Rubia Nieto A; Sánchez Garre MJ
Farm Hosp; 2007; 31(4):254-6. PubMed ID: 18052623
[No Abstract] [Full Text] [Related]
9. Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome before and after 3,4-diaminopyridine.
Sadeh M; River Y; Argov Z
Muscle Nerve; 1997 Jun; 20(6):735-9. PubMed ID: 9149081
[TBL] [Abstract][Full Text] [Related]
10. Single-fiber electromyography improvement with 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome.
Kim DS; Claussen GC; Oh SJ
Muscle Nerve; 1998 Aug; 21(8):1107-8. PubMed ID: 9655139
[No Abstract] [Full Text] [Related]
11. [Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
Matsushima M; Yaguchi H; Kishimoto R; Tsuji S; Yabe I; Sasaki H; Nakadate M; Shiraishi H; Motomura M
Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1709-11. PubMed ID: 17802724
[No Abstract] [Full Text] [Related]
12. Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J; Mills KR
Muscle Nerve; 1998 Sep; 21(9):1196-8. PubMed ID: 9703446
[TBL] [Abstract][Full Text] [Related]
13. Acute ventilatory failure in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine.
Smith AG; Wald J
Neurology; 1996 Apr; 46(4):1143-5. PubMed ID: 8780107
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome.
McEvoy KM; Windebank AJ; Daube JR; Low PA
N Engl J Med; 1989 Dec; 321(23):1567-71. PubMed ID: 2555713
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of the Eaton-Lambert myasthenic syndrome with 3,4-diaminopyridine].
Casanova B; Vílchez JJ; Rubio P
Rev Clin Esp; 1993 Apr; 192(7):354-5. PubMed ID: 8388576
[No Abstract] [Full Text] [Related]
16. Lambert Eaton syndrome: autonomic neuropathy and inappropriate antidiuretic hormone secretion in a patient with small cell carcinoma of the lung.
Manji H; Schwartz MS; McKeran RO
J Neurol; 1990 Aug; 237(5):324-5. PubMed ID: 2172471
[TBL] [Abstract][Full Text] [Related]
17. [Long-term treatment of Lambert-Eaton syndrome by 3, 4 diaminopyridine].
Jost WH; Mielke U; Forrett-Kaminsky MC; Schimrigk K
Rev Neurol (Paris); 1992; 148(12):776-9. PubMed ID: 1303573
[TBL] [Abstract][Full Text] [Related]
18. [Lambert-Eaton myasthenic syndrome: response to treatment with 3,4-diaminopyridine].
Morata C; Alfaro A; Chumillas MJ; Montalar J
Med Clin (Barc); 1995 Feb; 104(4):156. PubMed ID: 7898163
[No Abstract] [Full Text] [Related]
19. Amifampridine tablets for the treatment of Lambert-Eaton myasthenic syndrome.
Mantegazza R
Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1013-1018. PubMed ID: 31639317
[No Abstract] [Full Text] [Related]
20. Wide spectrum of symptomatic treatment in Lambert-Eaton myasthenic syndrome.
Oh SJ; Kim DS; Kwon KH; Tseng A; Mussell H; Claussen GC
Ann N Y Acad Sci; 1998 May; 841():827-31. PubMed ID: 9668337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
